Gastroenterology
Volume 142, Issue 1 , Pages 140-151.e12 , January 2012

Alterations in Lipid Metabolism Mediate Inflammation, Fibrosis, and Proliferation in a Mouse Model of Chronic Cholestatic Liver Injury

  • Tarek Moustafa

      Affiliations

    • Laboratory of Experimental and Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
    • Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
    • ,
  • Peter Fickert

      Affiliations

    • Laboratory of Experimental and Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
    • ,
  • Christoph Magnes

      Affiliations

    • HEALTH - Institute for Biomedicine and Health Sciences, Joanneum Research, Graz, Austria
    • ,
  • Christian Guelly

      Affiliations

    • Center for Medical Research, Medical University of Graz, Graz, Austria
    • ,
  • Andrea Thueringer

      Affiliations

    • Institute of Pathology, Medical University of Graz, Graz, Austria
    • ,
  • Sasa Frank

      Affiliations

    • Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria
    • ,
  • Dagmar Kratky

      Affiliations

    • Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria
    • ,
  • Wolfgang Sattler

      Affiliations

    • Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria
    • ,
  • Helga Reicher

      Affiliations

    • Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria
    • ,
  • Frank Sinner

      Affiliations

    • HEALTH - Institute for Biomedicine and Health Sciences, Joanneum Research, Graz, Austria
    • ,
  • Judith Gumhold

      Affiliations

    • Laboratory of Experimental and Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
    • ,
  • Dagmar Silbert

      Affiliations

    • Laboratory of Experimental and Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
    • ,
  • Günter Fauler

      Affiliations

    • Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria
    • ,
  • Gerald Höfler

      Affiliations

    • Institute of Pathology, Medical University of Graz, Graz, Austria
    • ,
  • Achim Lass

      Affiliations

    • Institute of Molecular Biosciences, University of Graz, Graz, Austria
    • ,
  • Rudolf Zechner

      Affiliations

    • Institute of Molecular Biosciences, University of Graz, Graz, Austria
    • ,
  • Michael Trauner

      Affiliations

    • Laboratory of Experimental and Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
    • Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationReprint requests Address requests for reprints to: Michael Trauner, MD, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Waehringerguertel 18-20, A-1090 Vienna, Austria

Received 31 January 2011 ,Accepted 29 September 2011.

References 

  1. Manos MM , Leyden WA , Murphy RC , et al.  Limitations of conventionally derived chronic liver disease mortality rates: results of a comprehensive assessment . Hepatology . 2008;47:1150–1157
  2. Martin M . Primary sclerosing cholangitis . Annu Rev Med . 1993;44:221–227
  3. Trauner M , Meier PJ , Boyer JL . Molecular pathogenesis of cholestasis . N Engl J Med . 1998;339:1217–1227
  4. Fickert P , Wagner M , Marschall HU , et al.  24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice . Gastroenterology . 2006;130:465–481
  5. Ziol M , Barbu V , Rosmorduc O , et al.  ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults . Gastroenterology . 2008;135:131–141
  6. Lefebvre P , Cariou B , Lien F , et al.  Role of bile acids and bile acid receptors in metabolic regulation . Physiol Rev . 2009;89:147–191
  7. Acalovschi M , Tirziu S , Chiorean E , et al.  Common variants of ABCB4 and ABCB11 and plasma lipid levels: a study in sib pairs with gallstones, and controls . Lipids . 2009;44:521–526
  8. Voshol PJ , Havinga R , Wolters H , et al.  Reduced plasma cholesterol and increased fecal sterol loss in multidrug resistance gene 2 P-glycoprotein-deficient mice . Gastroenterology . 1998;114:1024–1034
  9. Haemmerle G , Lass A , Zimmermann R , et al.  Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase . Science . 2006;312:734–737
  10. Sattler W , Reicher H , Ramos P , et al.  Preparation of fatty acid methyl esters from lipoprotein and macrophage lipid subclasses on thin-layer plates . Lipids . 1996;31:1302–1310
  11. Sokolovic M , Sokolovic A , van Roomen CP , et al.  Unexpected effects of fasting on murine lipid homeostasis—transcriptomic and lipid profiling . J Hepatol . 2010;52:737–744
  12. Jin W , Millar JS , Broedl U , et al.  Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo . J Clin Invest . 2003;111:357–362
  13. Kruit JK , Plosch T , Havinga R , et al.  Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice . Gastroenterology . 2005;128:147–156
  14. Voshol PJ , Minich DM , Havinga R , et al.  Postprandial chylomicron formation and fat absorption in multidrug resistance gene 2 P-glycoprotein-deficient mice . Gastroenterology . 2000;118:173–182
  15. Rakhshandehroo M , Sanderson LM , Matilainen M , et al.  Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling . PPAR Res . 2007;2007:26839
  16. Ishida T , Choi S , Kundu RK , et al.  Endothelial lipase is a major determinant of HDL level . J Clin Invest . 2003;111:347–355
  17. Barter PJ , Puranik R , Rye KA . New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease . Curr Cardiol Rep . 2007;9:493–498
  18. Mauad TH , van Nieuwkerk CM , Dingemans KP , et al.  Mice with homozygous disruption of the mdr2 P-glycoprotein gene (A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis) . Am J Pathol . 1994;145:1237–1245
  19. Mei S , Wang X , Zhang J , et al.  In vivo transfection of C/EBP-alpha gene could ameliorate CCL(4)-induced hepatic fibrosis in mice . Hepatol Res . 2007;37:531–539
  20. She H , Xiong S , Hazra S , et al.  Adipogenic transcriptional regulation of hepatic stellate cells . J Biol Chem . 2005;280:4959–4967
  21. Li ZZ , Berk M , McIntyre TM , et al.  Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase . J Biol Chem . 2009;284:5637–5644
  22. Yamaguchi K , Yang L , McCall S , et al.  Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis . Hepatology . 2007;45:1366–1374
  23. Sapiro JM , Mashek MT , Greenberg AS , et al.  Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity . J Lipid Res . 2009;50:1621–1629
  24. Nakajima T , Tanaka N , Kanbe H , et al.  Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism . Mol Pharmacol . 2009;75:782–792
  25. Macfarlane DP , Zou X , Andrew R , et al.  Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency; implications for the pathogenesis of steatohepatitis . Am J Physiol Endocrinol Metab . 2011;300:E402–E409
  26. Neuschwander-Tetri BA . Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites . Hepatology . 2010;52:774–788

 Watch this article's video abstract and others at http://tiny.cc/j026c.

 Conflicts of interest The authors disclose the following: The Medical University Graz has filed a patent on the use of 24-norUDCA in chronic liver disease, and Michael Trauner and Peter Fickert are listed as coinventors. The remaining authors disclose no conflicts.

 Funding Supported by grants P19118 and the SFB-Lipotox F30 from the Austrian Science Fund.

PII: S0016-5085(11)01377-1

doi: 10.1053/j.gastro.2011.09.051

Gastroenterology
Volume 142, Issue 1 , Pages 140-151.e12 , January 2012

Article Tools

* Image Usage & Resolution